Continuous Flow Side-Chain Alkylation for Ibuprofen Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current batch reaction processes for synthesizing ibuprofen raw materials are inefficient, leading to unstable product quality, high energy consumption, and poor conversion rates, making them unsuitable for large-scale production.
Innovation Solution
A continuous flow side-chain alkylation process and device that utilize a catalyst synthesis reactor, preheaters, a double-chamber coil reactor, and extraction towers to efficiently synthesize ibuprofen raw materials with improved purity and yield.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If batch reaction is adopted for synthesizing ibuprofen raw materials, then the process is flexible and easy to operate, but the product quality is unstable and energy consumption is high
Solution Approach 1:
The patent implements continuous flow reaction to replace batch reaction, enabling continuous processing of alkylbenzene side-chain alkylation. This continuous operation eliminates idle time between batches, maintains steady-state reaction conditions, and achieves stable product quality while reducing overall energy consumption through optimized heat management and continuous catalyst circulation.
2Productivity
If batch reaction is adopted for synthesizing ibuprofen raw materials, then the process can be easily controlled, but the conversion rate of alkylbenzene is poor
Solution Approach 1:
The continuous flow system maintains constant reaction conditions and continuous catalyst-substrate contact, achieving high conversion rates of alkylbenzene. The system processes materials continuously through the reaction zone, eliminating the start-stop nature of batch operations and maximizing resource utilization.
Solution Approach 2:
The patent employs a self-catalytic mechanism where the catalyst system automatically circulates and regenerates within the continuous flow system. The catalyst is continuously reused without manual intervention, and the system self-regulates the reaction conditions to maintain optimal conversion rates throughout continuous operation.
3Object-generated harmful factors
If batch reaction with iodine or palladium catalyst is used, then the reaction can proceed, but environmental pollution is serious and waste treatment is complicated
Solution Approach 1:
The patent replaces harmful iodine and palladium catalysts with a benign solid acid catalyst system. This substitution converts the harmful catalytic approach into a beneficial one, eliminating toxic waste generation while maintaining catalytic efficiency. The solid acid catalyst can be easily separated and reused, transforming a potential waste problem into a sustainable process feature.
Solution Approach 2:
The patent employs a solid acid catalyst that can be easily disposed of or regenerated without complex waste treatment procedures. Unlike precious metal catalysts that require sophisticated recovery systems, the solid acid catalyst simplifies the waste management process while maintaining effective catalytic activity for the alkylation reaction.
4Device complexity
If batch reaction is used with multiple intermediates, then various products can be synthesized, but the process is complex and production cost is high
Solution Approach 1:
The patent segments the multi-step batch process into a streamlined continuous flow sequence. By dividing the reaction into controlled stages within the continuous system and using a universal solid acid catalyst for all alkylation steps, the process complexity is reduced while maintaining the ability to produce various ibuprofen intermediates and final products.
Solution Approach 2:
The solid acid catalyst system demonstrates universality by effectively catalyzing multiple alkylation reactions required for different ibuprofen intermediates. This single catalyst type replaces the need for multiple specialized catalysts and reaction conditions, simplifying the overall process and reducing production costs across various product lines.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The continuous process achieves stable and high-purity ibuprofen raw material production with reduced side reactions, lower energy consumption, and simplified waste recovery, making it suitable for large-scale production.
Implementation Method 1
synthesizing a catalyst in the catalyst synthesis reactor using the raw material A
Implementation Method 2
transporting the catalyst and the alkylbenzene simultaneously into an alkylbenzene preheater to allow preheating; preheating the raw material B in an alkene preheater
Implementation Method 3
transporting the mixed solution as a reaction system into a double-chamber coil reactor to allow a continuous reaction to obtain an ibuprofen raw material
Implementation Method 4
cooling the reaction system after the continuous reaction is completed; the alkene was cooled to 20° C. by the cooler
Implementation Method 5
a remaining material entered a hydrocyclone F02 for separation to obtain a solid catalyst
Implementation Method 6
subjecting a system obtained after the quenching to continuous extraction with water as an extractant to transfer impurities into an aqueous phase, and separating remaining alkylbenzene and ibuprofen raw material by extraction with dimethyl sulfoxide (DMSO)
Implementation Method 7
introducing the remaining reaction liquid and a quencher into a quenching tank to allow quenching, such that a residual catalyst and other active substances are quenched
Data Source
AI summary
A process and a device for continuous flow side-chain alkylation which relate to the technical field of organic synthesis. In this process and the device for continuous flow side-chain alkylation, an ibuprofen raw material is prepared with alkylbenzene as a raw material. This raw material alkylbenzene is easily available and has a low cost, and is suitable for scale-up production. Moreover, an entire preparation process adopts continuous chemical synthesis, and a reaction time of each stage can be precisely controlled, which is beneficial to control a total reaction time and reduce an amount of impurities produced. In this way, a purity and a yield of the ibuprofen raw material are improved. In summary, a continuous synthesis method for side-chain alkylation of alkylbenzene provided by the present disclosure shows a low cost and a high yield.